Platte River Capital’s GSK GSK Stock Holding History

Platte River Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$643K	Sell	13,384 -9,552	-42%	-$497K	0.59%	55
2015 Q2	$1.19M	Sell	22,936 -17,688	-44%	-$996K	0.6%	56
2015 Q1	$2.34M	Sell	40,624 -11,832	-23%	-$678K	1.05%	31
2014 Q4	$2.8M	Sell	52,456 -23,360	-31%	-$1.31M	1.04%	31
2014 Q3	$4.36M	Sell	75,816 -31,128	-29%	-$1.91M	1.12%	24
2014 Q2	$7.15M	Sell	106,944 -21,664	-17%	-$1.47M	1.08%	22
2014 Q1	$8.59M	Sell	128,608 -6,464	-5%	-$437K	1.16%	15
2013 Q4	$9.01M	Sell	135,072 -9,256	-6%	-$600K	1.16%	19
2013 Q3	$9.05M	Sell	144,328 -8,208	-5%	-$528K	1.12%	20
2013 Q2	$9.53M	Buy	+152,536	New	+$9.68M	1.11%	22

Other funds holding GSK

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Platte River Capital's GSK Position: Q3 2015 in Review

Platte River Capital reduced its GSK (GSK) stake by 42% in Q3 2015, selling an estimated $497K and leaving 13,384 shares worth $643K. The position accounts for 0.59% of the portfolio, ranked #55.

Platte River Capital first reported a position in GSK in Q2 2013 and has held it in 10 quarters since. The position peaked at $9.53M in Q2 2013. 706 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

Platte River Capital held 13,384 shares of GSK worth $643K as of Q3 2015.
Platte River Capital sold 9,552 GSK shares in Q3 2015, an estimated $497K.
GSK made up 0.59% of Platte River Capital's portfolio in Q3 2015, its #55 holding.
Platte River Capital first reported a position in GSK in Q2 2013 and has held it in 10 quarters since.
Platte River Capital's GSK position peaked at $9.53M in Q2 2013.
706 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on Platte River Capital's 13F filing for Q3 2015, filed 12 Nov 2015.